Increased expression of Annexin A2 in oral squamous cell carcinoma

Archives of Oral Biology

Volumn 54, Issue 1, 2009, Pages 17-25

  Zhong, Lai ping ^a,b   Wei, Kui jie ^a,b   Yang, Xiao ^a,b   Zhang, Lei ^a,b   Zhou, Xiao jian ^a,b   Pan, Hong ya ^a,b   Li, Jiang ^a,b   Chen, Wan tao ^a,b   Zhang, Zhi yuan ^a,b  

^a Chongqing Ninth People's Hospital   (China)

^b Shanghai Research Institute of Stomatology   (China)

Author keywords

Annexin A2; Cellular carcinogenesis model; Comparative proteomics; Gene expression; Oral squamous cell carcinoma

Indexed keywords

LIPOCORTIN 2; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANNEXIN A2; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 56549084173     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2008.08.006     Document Type: Article

References (49)

1. Kademani D. Oral cancer. Mayo Clin Proc 82 (2007) 878-887
2. Petersen P.E. The World Oral Health Report 2003: continuous improvement of oral health in the 21st century-the approach of WHO Global Oral Programme. Commun Dent Oral Epidemiol 31 suppl. (2003) 3-23
3. Neville B.W., and Day T.A. Oral cancer and precancerous lesions. CA Cancer J Clin 52 (2002) 195-215
4. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
5. Zhong L.P., Pan H.Y., Zhou X.J., Ye D.X., Zhang L., Yang X., et al. Characteristics of a cancerous cell line, HIOEC-B(a)P-96, induced by benzo(a)pyrene from human immortalized oral epithelial cell line. Arch Oral Biol 53 (2008) 443-452
6. Sdek P., Zhang Z.Y., Cao J., Pan H.Y., Chen W.T., and Zheng J.W. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. Int J Oral Maxillofac Surg 35 (2006) 653-657
7. He Q.Y., Chen J., Kung H.F., Yuen A.P., and Chiu J.F. Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 4 (2004) 271-278
8. Chen J., He Q.Y., Yuen A.P., and Chiu J.F. Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 4 (2004) 2465-2475
9. Turhani D., Krapfenbauer K., Thurnher D., Langen H., and Fountoulakis M. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 27 (2006) 1417-1423
10. Lo W.Y., Tsai M.H., Tsai Y., Hua C.H., Tsai F.J., Huang S.Y., et al. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta 376 (2007) 101-107
11. Koike H., Uzawa K., Nakashima D., Shimada K., Kato Y., Higo M., et al. Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. Int J Oncol 27 (2005) 59-67
12. Mlynarek A.M., Balys R.L., Su J., Hier M.P., Black M.J., and Alaoui-Jamali M.A. A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 133 (2007) 910-918
13. Staab C.A., Ceder R., Jägerbrink T., Nilsson J.A., Roberg K., Jörnvall H., et al. Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma. J Proteome Res 6 (2007) 3705-3717
14. Waisman D.M. Annexin II tetramer: structure and function. Mol Cell Biochem 149-150 (1995) 301-322
15. Singh P. Role of Annexin-II in GI cancers: interaction with gastrins/progastrins. Cancer Lett 252 (2007) 19-35
16. Burger A., Berendes R., Liemann S., Benz J., Hofmann A., Göttig P., et al. The crystal structure and ion channel activity of human annexin II, a peripheral membrane protein. J Mol Biol 257 (1996) 839-847
17. Chiang Y., Rizzino A., Sibenaller Z.A., Wold M.S., and Vishwanatha J.K. Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol Cell Biochem 199 (1999) 139-147
18. Ling Q., and Hajjar K.A. Inhibition of endothelial cell thromboresistance by homocysteine. J Nutr 130 (2000) 373S-376S
19. Liu L., Tao J.Q., and Zimmerman U.J. Annexin II binds to the membrane of A549 cells in a calcium-dependent and calcium-independent manner. Cell Signal 9 (1997) 299-304
20. Frohlich M., Motté P., Galvin K., Takahashi H., Wands J., and Ozturk M. Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. Mol Cell Biol 10 (1990) 3216-3223
21. Vishwanatha J.K., Chiang Y., Kumble K.D., Hollingsworth M.A., and Pour P.M. Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis 14 (1993) 2575-2579
22. Chen R., Brentnall T.A., Pan S., Cooke K., Moyes K.W., Lane Z., et al. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics 6 (2007) 1331-1342
23. Reeves S.A., Chavez-Kappel C., Davis R., Rosenblum M., and Israel M.A. Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma. Cancer Res 52 (1992) 6871-6876
24. Roseman B.J., Bollen A., Hsu J., Lamborn K., and Israel M.A. Annexin II marks astrocytic brain tumors of high histologic grade. Oncol Res 6 (1994) 561-567
25. Emoto K., Sawada H., Yamada Y., Fujimoto H., Takahama Y., Ueno M., et al. Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res 21 (2001) 1339-1345
26. Menell J.S., Cesarman G.M., Jacovina A.T., McLaughlin M.A., Lev E.A., Hajjar K.A., et al. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 340 (1999) 994-1004
27. Tomonaga T., Matsushita K., Yamaguchi S., Oh-Ishi M., Kodera Y., Maeda T., et al. Identification of altered protein expression and posttranslational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis. Clin Cancer Res 10 (2004) 2007-2014
28. Emoto K., Yamada Y., Sawada H., Fujimoto H., Ueno M., Takayama T., et al. Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer 92 (2001) 1419-1426
29. Sharma M.R., Koltowski L., Ownbey R.T., Tuszynski G.P., and Sharma M.C. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol 81 (2006) 146-156
30. Cole S.P., Pinkoski M.J., Bhardwaj G., and Deeley R.G. Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. Br J Cancer 65 (1992) 498-502
31. Bae S.M., Lee C.H., Cho Y.L., Nam K.H., Kim Y.W., Kim C.K., et al. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol 99 (2005) 26-35
32. Pena-Alonso E., Rodrigo J.P., Parra I.C., Pedrero J.M., Meana M.V., Nieto C.S., et al. Annexin A2 localizes to the basal epithelial layer and is down-regulated in dysplasia and head and neck squamous cell carcinoma. Cancer Lett 263 (2008) 89-98
33. Yee D.S., Narula N., Ramzy I., Boker J., Ahlering T.E., Skarecky D.W., et al. Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Arch Pathol Lab Med 131 (2007) 902-908
34. Liu J.W., Shen J.J., Tanzillo-Swarts A., Bhatia B., Maldonado C.M., Person M.D., et al. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 22 (2003) 1475-1485
35. Qi Y.J., He Q.Y., Ma Y.F., Du Y.W., Liu G.C., Li Y.J., et al. Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma. J Cell Biochem 104 (2008) 1625-1635
36. Xiong X.D., Xu L.Y., Shen Z.Y., Cai W.J., Luo J.M., Han Y.L., et al. Identification of differentially expressed proteins between human esophageal immortalized and carcinomatous cell lines by two-dimensional electrophoresis and MALDI-TOF-mass spectrometry. World J Gastroenterol 8 (2002) 777-781
37. Zhong L.P., Chen W.T., Zhang C.P., and Zhang Z.Y. Increased CK19 expression correlated with pathologic differentiation grade and prognosis in oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 (2007) 377-384
38. Zhong L.P., Zhang C.P., Li J., Chen W.T., and Zhang Z.Y. Increase of Cyfra 21-1 concentration in saliva from oral squamous cell carcinoma patients. Arch Oral Biol 52 (2007) 1079-1087
39. Sobin L.H., and Wittekind C.H. International Union Against Cancer (UICC). TNM classification of malignant tumours. 6th ed. (1997), Wiley-Liss, Inc., New York p. 22-26
40. Barnes L., Eveson J.W., Reichart P., and Sidransky D. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours (2005), IARC Press, Lyon p. 168-175
41. -ΔΔCt method. Methods 25 (2001) 402-408
42. Zhong L.P., Li J., Zhang C.P., Zhu H.G., Sun J., and Zhang Z.Y. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Arch Oral Biol 52 (2007) 740-747
43. Babbin B.A., Parkos C.A., Mandell K.J., Winfree L.M., Laur O., Ivanov A.I., et al. Annexin 2 regulates intestinal epithelial cell spreading and wound closure through Rho-related signaling. Am J Pathol 170 (2007) 951-966
44. Ling Q., Jacovina A.T., Deora A., Febbraio M., Simantov R., Silverstein R.L., et al. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest 113 (2004) 38-48
45. Mai J., Waisman D.M., and Sloane B.F. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim Biophys Acta 1477 (2000) 215-230
46. Keutzer J.C., and Hirschhorn R.R. The growth-regulated gene 1B6 is identified as the heavy chain of calpactin I. Exp Cell Res 188 (1990) 153-159
47. Monsonego J., Bosch F.X., Coursaget P., Cox J.T., Franco E., Frazer I., et al. Cervical cancer control, priorities and new directions. Int J Cancer 108 (2004) 329-333
48. Waggoner S.E. Cervical cancer. Lancet 361 (2003) 2217-2225
49. Zimmermann U., Woenckhaus C., Pietschmann S., Junker H., Maile S., Schultz K., et al. Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome. Virchows Arch 445 (2004) 368-374